Intramuscular (IM) Ketamine
IM ketamine is often favored when the clinical goal is a deeper, more psycholytic experience for therapeutic processing.
This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.
Profile
- Bioavailability: ~93%.
- Onset: 5–10 minutes.
- Duration of acute effects: 45–90 minutes.
- Titration: none after injection.
- Setting: medical or KAP clinic with monitoring.
Strengths
- Lower equipment overhead than IV.
- Often paired with psychotherapy (KAP) at higher doses.
- Cost typically below IV per session.
Trade-offs
- No real-time dose control once injected.
- Smaller depression-specific evidence base than IV.
- Experience can be more intense — appropriate screening matters.
Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.